What's new

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 10, Status: Authorised

Jun 17, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Trumenba, meningococca...

Next Article

Human medicines European public assessment report (EPAR): Tyenne, tocilizumab, D...

Related Posts

European Society of Cardiology (ESC) bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2025, 15:00 (CEST) to 22 May 2025, 17:00 (CEST)

European Society of Cardiology (ESC) bilateral meeting,...

May 21, 2025  0

Human medicines European public assessment report (EPAR): Orencia, abatacept, Date of authorisation: 21/05/2007, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Pedea, ibuprofen, Date of authorisation: 28/07/2004, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0